Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/05/2791335/37216/en/Aclaris-Therapeutics-Announces-Patent-License-Agreement-with-Sun-Pharma-for-Alopecia.html

WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases, today announced an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc. (Sun Pharma).

Read more at globenewswire.com

Related news for (ACRS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.